Motexafin Gadolinium

From Handwiki

Short description: Chemical compound
Motexafin gadolinium
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
Chemical and physical data
FormulaC52H72GdN5O14
Molar mass1148.42 g·mol−1
3D model (JSmol)
  (verify)

Motexafin gadolinium (proposed tradename Xcytrin) is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible chemotherapeutic agent in the treatment of brain metastases.[1]

History

On May 9, 2006, a New Drug Application was submitted to the United States Food and Drug Administration (FDA) by Pharmacyclics, Inc.[2]

In December 2007, the FDA issued a not approvable letter for motexafin gadolinium.[3]

References





Categories: [Organogadolinium compounds]


Download as ZWI file | Last modified: 06/11/2026 09:33:37 | 8 views
☰ Source: https://handwiki.org/wiki/Chemistry:Motexafin_gadolinium | License: CC BY-SA 3.0

ZWI is not signed. [what is this?]